Rate of MetS Unchanged after One Year of GH Replacement

Results of a new study highlight the importance of intensive treatment of all comorbidities associated with adult growth hormone deficiency.

Related Videos
Related Content

Earlier Age at Diabetes Onset Confers Greater Risk of Dementia Later in Life

May 25th 2023

Diabetes Dialogue: What to Know about the iLet Bionic Pancreas

May 26th 2023

Study Details Cancer Incidence, Mortality in Type 1 Diabetes from UK

May 16th 2023

Diabetes Dialogue: ADCES DTC 22, with Jennifer Okemah, RD, and Gary Scheiner, MS

January 21st 2023

Study Finds Only 1 in 4 with Diabetes in the US are Achieving Treatment Goals

May 11th 2023

Increased Physical Activity Could Slow Progression to Type 1 Diabetes in Autoantibody-Positive Children

May 11th 2023

Earlier Age at Diabetes Onset Confers Greater Risk of Dementia Later in Life

May 25th 2023

Diabetes Dialogue: What to Know about the iLet Bionic Pancreas

May 26th 2023

Study Details Cancer Incidence, Mortality in Type 1 Diabetes from UK

May 16th 2023

Diabetes Dialogue: ADCES DTC 22, with Jennifer Okemah, RD, and Gary Scheiner, MS

January 21st 2023

Study Finds Only 1 in 4 with Diabetes in the US are Achieving Treatment Goals

May 11th 2023

Increased Physical Activity Could Slow Progression to Type 1 Diabetes in Autoantibody-Positive Children

May 11th 2023

Earlier Age at Diabetes Onset Confers Greater Risk of Dementia Later in Life

May 25th 2023

Diabetes Dialogue: What to Know about the iLet Bionic Pancreas

May 26th 2023

Study Details Cancer Incidence, Mortality in Type 1 Diabetes from UK

May 16th 2023

Diabetes Dialogue: ADCES DTC 22, with Jennifer Okemah, RD, and Gary Scheiner, MS

January 21st 2023

Study Finds Only 1 in 4 with Diabetes in the US are Achieving Treatment Goals

May 11th 2023

Increased Physical Activity Could Slow Progression to Type 1 Diabetes in Autoantibody-Positive Children

May 11th 2023
© 2023 MJH Life Sciences

All rights reserved.